modelRosuvastatin_Macpherson2016_final

Extends from Pharmacolibrary.Pharmacokinetic.Models.PK_1C_enteral.

Information

name:rosuvastatin
ATC code:C10AA07
model:one compartment, oral dosing (PK_1C_enteral)
source:Macpherson M et al. 2016
population:pediatric patients with heterozygous familial hypercholesterolemia
measured compound:rosuvastatin
review:curated candidate
record page:pharmacolibrary-docs

Parameters as reported in the paper

parametervalueunitmeaning
Ka (h-1)0.183h-1kabs
CL/F (L/h)157L/hCL/F
Vc/F (L)316LV/F
Q/F (L/h)92.3L/hQ/F

About rosuvastatin

Rosuvastatin is a statin used to treat lipid metabolism disorders such as hypercholesterolemia, atherosclerosis, and related heart disease. It is an approved medicine, widely used, and also available in fixed combinations with other lipid-modifying agents.

Summary written by glm-5.3-flash from Wikidata Q415159 and the WHO ATC classification; not checked by a person.

Identity, molar mass and metabolites: Rosuvastatin.

References

  1. Macpherson M et al. (2016). Population pharmacokinetics of rosuvastatin in pediatric patients with heterozygous familial hypercholesterolemia. European journal of clinical pharmacology 72(1):19–27. DOI:10.1007/s00228-015-1946-4 PUBMED:26387811

Parameters

TypeNameDefaultDescription
RealCl_ref4.361111111111111e-05Cl [m3/s]
RealVd_ref0.316Vd [m3]
Modelica.Units.SI.Massweight (from PK_1C)75patient weight (kg)
Modelica.Units.SI.SpecificVolumeVdPerKg (from PK_1C)0.0009Volume of distribution per kg (default 0.9 L/kg)
Modelica.Units.SI.MassFractionF (from PK_1C)1bioavailability (0-1)
Pharmacolibrary.Types.ClearanceCl (from PK_1C)2.7777777777777776e-7clearance
Modelica.Units.SI.TimeadminTime (from PK_1C)60first administration time (s)
Modelica.Units.SI.TimeadminDuration (from PK_1C)600administration duration (s)
Modelica.Units.SI.TimeadminPeriod (from PK_1C)8*60*60period of administration (default 8 hours)(s)
Pharmacolibrary.Types.MassadminMass (from PK_1C)1e-4administration mass (mg)
IntegeradminCount (from PK_1C)8number of dose administered (1)
Pharmacolibrary.Types.VolumeVd (from PK_1C)VdPerKg*weightVolume of distribution (m3)
Pharmacolibrary.Types.TransferRateka (from PK_1C_enteral)0.016666666666666666first order absorption rate
Modelica.Units.SI.TimeTlag (from PK_1C_enteral)600delay between oral administration and absorption (default 10min)
Info › Therapeutic range (metadata, not used in equations)
Pharmacolibrary.Types.MassConcentrationCmin (from PK_1C)0.004minimal therapeutic range
Pharmacolibrary.Types.MassConcentrationCmax (from PK_1C)0.008maximal therapeutic range
Pharmacolibrary.Types.MassConcentrationCtox_peak (from PK_1C)0.012toxicity peak level
Pharmacolibrary.Types.MassConcentrationCtox_trough (from PK_1C)0.006toxicity trough level
Info › Substance metadata
Modelica.Units.SI.MolarMassMM (from PK_1C)0molar mass [kg/mol]; 0 = not supplied (molar concentrations are then 0)
Info › Substance metadata (not used in equations)
Pharmacolibrary.Types.DoseLD50 (from PK_1C)0median lethal dose [mg/kg]; 0 = unknown

Connectors

TypeNameDefaultDescription
Types.ConcentrationOutputC_central (from PK_1C)
Interfaces.ConcentrationPort_bcentralCPort (from PK_1C)

Components

TypeNameDefaultDescription
Pharmacokinetic.NoPerfusedTissueCompartmentcentral (from PK_1C)
Pharmacokinetic.ClearanceDrivenEliminationelim (from PK_1C)
Sources.PeriodicDoseperiodicDose (from PK_1C)
Modelica.Units.SI.Timet1_2 (from PK_1C)central-compartment elimination half-life = ln(2)*Vd/Cl (1-compartment approximation; NOT the terminal half-life of 2-/3-compartment models)

Revisions

  • 11/2026 generated by pharmacolibrary-dev export.pharmacolibrary_models from Macpherson_2016: parameters extracted from the paper by the pharmacolibrary-dev pipeline, model built by its engineer, reviewed: curated candidate